Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

AC Immune (ACIU) EBT Margin (2016 - 2026)

AC Immune has reported EBT Margin over the past 9 years, most recently at 1322.7% for Q1 2026.

  • Quarterly EBT Margin rose 59942.0% to 1322.7% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 1787.93% through Mar 2026, down 160984.0% year-over-year, with the annual reading at 1971.65% for FY2025, 178522.0% down from the prior year.
  • EBT Margin was 1322.7% for Q1 2026 at AC Immune, up from 4252.37% in the prior quarter.
  • Over five years, EBT Margin peaked at 21.59% in Q3 2024 and troughed at 4252.37% in Q4 2025.
  • The 4-year median for EBT Margin is 1622.43% (2025), against an average of 1759.48%.
  • The largest YoY upside for EBT Margin was 169052bps in 2025 against a maximum downside of -286327bps in 2025.
  • A 4-year view of EBT Margin shows it stood at 346.46% in 2022, then tumbled by -301bps to 1389.09% in 2024, then plummeted by -206bps to 4252.37% in 2025, then skyrocketed by 69bps to 1322.7% in 2026.
  • Per Business Quant, the three most recent readings for ACIU's EBT Margin are 1322.7% (Q1 2026), 4252.37% (Q4 2025), and 1688.82% (Q3 2025).